Each year, the ARCS Annual Conference offers more than just a professional development opportunity—it provides a moment to pause, connect, and step forward with renewed purpose. In 2025, under the theme Beyond Boundaries: Advancing Professionalism, the conference brings together the breadth of Australia’s medtech, biotech, and pharmaceutical ecosystem for three days of learning, insight, and collaboration.

Held from 3–5 June at the International Convention Centre (ICC) in Sydney, and aligned with the city’s spectacular Vivid Festival, this year’s conference invites delegates to look beyond traditional silos and explore what professionalism means in a sector undergoing significant transformation.

Advancing the Conversation on Regulation, Innovation and Capability

Day 1 of the conference sets a strong tone, balancing regulatory fundamentals with discussions on equity and cross-functional practice. The opening session, featuring The Smith Family Tertiary Program, challenges us to consider how we support and diversify our future workforce—an issue of growing relevance for employers and educators alike.

Across the day, delegates will hear from the Therapeutic Goods Administration (TGA), Medsafe (New Zealand), and state representatives from Victoria and the Northern Territory. Their updates will provide a forward-looking view of regional regulatory priorities, reforms in clinical trials, and the policy shifts shaping our operating environment.

A key feature of Day 1 is the ARCS Medical Devices Summit—a deep dive into the increasingly complex space of device and combination product regulation. With dedicated speakers from both local and global contexts, the Summit will explore how regulation must evolve to support emerging technologies, novel therapies, and hybrid product models.

Sessions on market access, GxP agreements, and medical affairs capability round out the day, offering practical insights across core disciplines and encouraging alignment in evidence planning, operational leadership, and strategy execution.

Looking Ahead: Innovation, Technology and Sector Strategy

Day 2 pivots to the future. The Sector Futures Plenary will bring together the CEOs of Australia’s major life sciences peak bodies to ask: Where are we headed in the next 5–10 years? This bold and timely conversation will examine leadership, workforce, sustainability, and the strategic decisions we must make as a sector to remain competitive and credible.

Digital health and AI are strong features across the day, with standout sessions on artificial intelligence in pharmacovigilance, the use of decentralised platforms in clinical trials, and real-world data applications for evidence generation. Whether you are working in regulatory science, quality assurance, or clinical operations, these sessions offer practical pathways to embed innovation in everyday practice.

You will hear more from the TGA with updates spanning regulatory science, clinical trials, and pharmacovigilance—including topics on Complementary Medicines. Real-world case studies explore the hurdles and strategies in pricing and reimbursement submissions.

The second day concludes with the MTP Sector Awards Dinner, where we recognise excellence across the sector. Held at Dockside, Cockle Bay Wharf and coinciding with Vivid Sydney, the evening promises celebration, connection, and inspiration.

Building the Future: Skills, Systems and Sector Reform

Day 3 is designed for those leading change—from organisational capability to national policy reform.

The morning begins with a compelling case study tracing an Australian innovation from bench to bedside, a reminder of the long-term impact of the work we do. This is followed by a deep focus on clinical research governance, including the National One Stop Shop, site readiness, activation timelines, and the growing role of consumer engagement in trial design.

Day 3 shines a spotlight on key issues shaping the future of clinical research, including Australia's positioning as a destination for early phase clinical trials. Sessions will explore how precision medicine is reshaping trial design and regulatory considerations, and how Australia–China collaborations are opening new opportunities for global research partnerships. The program also places a strong emphasis on inclusivity and diversity in clinical trials, highlighting the importance of broader representation in improving scientific validity, patient outcomes, and health equity.

The conference will conclude with a keynote from Sam Cawthorn, a globally renowned speaker and author whose journey from personal adversity to international influence is both powerful and practical. His session will send delegates home with a renewed sense of resilience, vision, and momentum.

Why This Conference Matters

The 2025 ARCS Annual Conference has been purposefully designed to meet the needs of professionals across the entire product lifecycle—regulatory affairs, clinical trials, pharmacovigilance, quality, market access, medical affairs, and beyond.

In an environment where the pace of change continues to accelerate, the conference is an anchor: a space to pause, reflect, grow, and connect. With more than 150 speakers, curated content across all three days, and networking opportunities that bring the entire sector together, there is no other event quite like it in Australia.

If you work in—or with—the Pharmaceutical and Med-Tech sector, this is your moment to join the conversation, sharpen your capability, and help shape what professionalism looks like in a future-focused health system.

Secure your place today: Visit www.arcs.com.au to view the full program and register.Early bird pricing available for Members for a limited time – don’t miss out.